Breast Cancer Research and COVID
Our speaker, Dr Sheeba Irshad, is a Senior Clinical Lecturer and Breast Cancer Medical Oncologist at King’s College London and Guy’s & St Thomas’ NHS Trust.
On her return in 2018 from The Sidney Kimmel Comprehensive Cancer Center at John’s Hopkins University in Baltimore, she was appointed as a Clinical Deputy Head of King’s College London Breast Cancer Now Research Unit Programme.
Dr Irshad specialises in researching hard to treat breast cancers, such as those that are resistant to chemotherapy. Her research is focused on understanding the tumour-immune cell cross talk in chemotherapy resistant cancers with particular emphasis on understanding mechanisms that underpin how cells from the immune system move within tumours. The goal is to find effective immunotherapy treatments for patients.
Dr Irshad is also the translational lead and coordinating investigator for a clinical trial platform to explore the potential interactions between DNA damage response inhibitors and immunotherapy in high-risk Triple Negative Breast Cancers.
More recently, Dr Irshad has led a multi-centre clinical study investigating the immune responses against Sars-Cov-2 in cancer patients.